Paper40313147
Antifungal effects of Metformin against Candida albicans by autophagy regulation.
Zhao X and 5 others. J Microbiol, 2025. Cited by 6 papers, by iCite.
Cite this record
ConductScience Library. Antifungal effects of Metformin against Candida albicans by autophagy regulation. Papers, record 40313147. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/40313147
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics12
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Candida albicans | Major topic |
| Antifungal Agents | Major topic |
| Autophagy | Major topic |
| Metformin | Major topic |
| Reactive Oxygen Species | |
| Biofilms | |
| Hyphae | |
| Membrane Potential, Mitochondrial | |
| Microbial Sensitivity Tests | |
| Amphotericin B | |
| Drug Synergism | |
| Caspofungin |
Source PubMed
Grants1
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| 81970945 | National Natural Science Foundation of China | PubMed |
Source PubMed
References55
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 36590591 | Repurposing non-antifungal drugs auranofin and pentamidine in combination as fungistatic antifungal agents against C. albicans. | Front Cell Infect Microbiol | 2022 | https://conductscience.org/library/papers/36590591 | PubMed |
| 2 | 24907229 | A new model for mitochondrial membrane potential production and storage. | Med Hypotheses | 2014 | https://conductscience.org/library/papers/24907229 | PubMed |
| 3 | 28258677 | Metformin - its potential anti-cancer and anti-aging effects. | Postepy Hig Med Dosw (Online) | 2017 | https://conductscience.org/library/papers/28258677 | PubMed |
| 4 | 22106223 | Possible inhibitory molecular mechanism of farnesol on the development of fluconazole resistance in Candida albicans biofilm. | Antimicrob Agents Chemother | 2012 | https://conductscience.org/library/papers/22106223 | PubMed |
| 5 | 38612411 | Anti-Biofilm Activity of Assamsaponin A, Theasaponin E1, and Theasaponin E2 against Candida albicans. | Int J Mol Sci | 2024 | https://conductscience.org/library/papers/38612411 | PubMed |
| 6 | 31399349 | Insights on the anticandidal activity of non-antifungal drugs. | J Mycol Med | 2019 | https://conductscience.org/library/papers/31399349 | PubMed |
| 7 | 37268905 | Synergistic apoptosis by combination of metformin and an O-GlcNAcylation inhibitor in colon cancer cells. | Cancer Cell Int | 2023 | https://conductscience.org/library/papers/37268905 | PubMed |
| 8 | 39338275 | Exploring the Antibiofilm Effect of Sertraline in Synergy with Cinnamomum verum Essential Oil to Counteract Candida Species. | Pharmaceuticals (Basel) | 2024 | https://conductscience.org/library/papers/39338275 | PubMed |
| 9 | 38679957 | Implications and hidden toxicity of cardiometabolic syndrome and early-stage heart failure in carfilzomib-induced cardiotoxicity. | Br J Pharmacol | 2024 | https://conductscience.org/library/papers/38679957 | PubMed |
| 10 | 31085405 | Candida albicans biofilm growth and dispersal: contributions to pathogenesis. | Curr Opin Microbiol | 2019 | https://conductscience.org/library/papers/31085405 | PubMed |
| 11 | 25017630 | Effects of metformin and other biguanides on oxidative phosphorylation in mitochondria. | Biochem J | 2014 | https://conductscience.org/library/papers/25017630 | PubMed |
| 12 | 31827709 | Metformin Suppresses Self-Renewal Ability and Tumorigenicity of Osteosarcoma Stem Cells via Reactive Oxygen Species-Mediated Apoptosis and Autophagy. | Oxid Med Cell Longev | 2019 | https://conductscience.org/library/papers/31827709 | PubMed |
| 13 | 38680098 | The underlying mechanism of calcium toxicity-induced autophagic cell death and lysosomal degradation in early stage of cerebral ischemia. | Anat Cell Biol | 2024 | https://conductscience.org/library/papers/38680098 | PubMed |
| 14 | 32596101 | Metformin Restores Tetracyclines Susceptibility against Multidrug Resistant Bacteria. | Adv Sci (Weinh) | 2020 | https://conductscience.org/library/papers/32596101 | PubMed |
| 15 | 25752309 | Synergistic and drug-resistant reversing effects of diorcinol D combined with fluconazole against Candida albicans. | FEMS Yeast Res | 2015 | https://conductscience.org/library/papers/25752309 | PubMed |
| 16 | 32765083 | Metformin Induces Autophagy via the AMPK-mTOR Signaling Pathway in Human Hepatocellular Carcinoma Cells. | Cancer Manag Res | 2020 | https://conductscience.org/library/papers/32765083 | PubMed |
| 17 | 33524789 | The effects of metformin on autophagy. | Biomed Pharmacother | 2021 | https://conductscience.org/library/papers/33524789 | PubMed |
| 18 | 22391539 | In vitro interactions between aspirin and amphotericin B against planktonic cells and biofilm cells of Candida albicans and C. parapsilosis. | Antimicrob Agents Chemother | 2012 | https://conductscience.org/library/papers/22391539 | PubMed |
| 19 | 36649220 | Antifungal Drug Concentration Impacts the Spectrum of Adaptive Mutations in Candida albicans. | Mol Biol Evol | 2023 | https://conductscience.org/library/papers/36649220 | PubMed |
| 20 | 37233275 | Fungal Drug Response and Antimicrobial Resistance. | J Fungi (Basel) | 2023 | https://conductscience.org/library/papers/37233275 | PubMed |
Cited by3
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 6 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42799968 | HOM2 and TPK1 are associated with Kluyveromyces marxianus growth under high-temperature and reduced-aeration conditions. | World J Microbiol Biotechnol | 2026 | https://conductscience.org/library/papers/42799968 | PubMed |
| 42353707 | Metformin as a Metabolic Reprogramming Interface in Host-Pathogen and Bone Microenvironment Crosstalk: A Dual-Target Strategy Against Antimicrobial Resistance and Osteoporotic Bone Loss. | Antibiotics (Basel) | 2026 | https://conductscience.org/library/papers/42353707 | PubMed |
| 40900204 | Chloroquine Alone and Combined with Antifungal Drug Against Candida albicans Biofilms In Vitro and In Vivo via Autophagy Inhibition. | Mycopathologia | 2025 | https://conductscience.org/library/papers/40900204 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/40313147
GET https://conductscience.org/api/papers/v1/40313147/references?page=2